Clinical measures in transthyretin familial amyloid polyneuropathy

被引：53
|
作者：
Coelho, Teresa [1 ]
Vinik, Aaron [2 ]
Vinik, Etta J. [2 ]
Tripp, Tara [3 ]
Packman, Jeff [4 ]
Grogan, Donna R. [4 ]
机构：
[1] Hosp Santo Antonio, Ctr Hosp Porto, P-4099001 Oporto, Portugal
[2] Eastern Virginia Med Sch, Strelitz Diabet Ctr, Norfolk, VA 23501 USA
[3] DM Stat Inc, Malden, MA USA
[4] FoldRx Pharmaceut Inc, Cambridge, MA USA
来源：
MUSCLE & NERVE | 2017年 / 55卷 / 03期
关键词：
amyloidosis; modified body mass index; nerve fiber function; Neuropathy Impairment Score; Norfolk Quality of Life; ROCHESTER DIABETIC-NEUROPATHY; RETINOL-BINDING-PROTEIN; LIVER-TRANSPLANTATION; FOLLOW-UP; PERIPHERAL NEUROPATHY; END-POINTS; TAFAMIDIS; SURVIVAL; TRIAL; DYSFUNCTION;
D O I：
10.1002/mus.25257
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
IntroductionThis observational, cross-sectional, single-center study aimed to identify instruments capable of measuring disease progression in transthyretin familial amyloid polyneuropathy (TTR-FAP). MethodsThe relationship between disease stage and Neuropathy Impairment Score-Lower Limbs (NIS-LL) and Norfolk Quality of Life-Diabetic Neuropathy (Norfolk QOL-DN) total score was assessed in 61 (stages 1-3) patients with TTR-FAP (V30M variant) and 16 healthy controls. Composite measures of large- and small-nerve fiber function, and modified body mass index (mBMI) were also assessed. ResultsOrdinal-based NIS-LL and Norfolk QOL-DN scores discriminated between disease stages (P<0.0001 for NIS-LL and Norfolk QOL-DN). Longer disease duration correlated with worse NIS-LL and Norfolk QOL-DN. Karnofsky performance score declined progressively by disease stage. Composite measures of nerve fiber function differentiated stage 1 from stage 2 disease. The mBMI declined with advancing disease. ConclusionsNIS-LL, Norfolk QOL-DN score, composite endpoints of nerve fiber function, and mBMI are valid, reliable measures of TTR-FAP severity. Muscle Nerve55: 323-332, 2017
引用
收藏
页码：323 / 332
页数：10
相关论文
共 50 条
  • [41] Transthyretin-related familial amyloid polyneuropathy (ATTR-FAP) in Poland - genetic and clinical presentation
    Lipowska, Marta
    Drac, Hanna
    Rowczenio, Dorota
    Gilbertson, Janet
    Hawkins, Philip N.
    Lasek-Bal, Anetta
    Szewczuk, Janusz
    Grzybowski, Jacek
    Gawor, Monika
    Stepien-Wojno, Malgorzata
    Franaszczyk, Maria
    Brydak-Godowska, Joanna
    Smierciak, Renata
    Ptasinska-Perkowska, Agnieszka
    Chandoga, Jan
    Petrovic, Robert
    Kostera-Pruszczyk, Anna
    NEUROLOGIA I NEUROCHIRURGIA POLSKA, 2020, 54 (06) : 552 - 560
  • [42] Treatment of familial amyloid polyneuropathy
    Adams, David
    Samuel, Didier
    Slama, Michel
    PRESSE MEDICALE, 2012, 41 (09): : 793 - 806
  • [43] Post Hoc Analysis of Nutritional Status in Patients with Transthyretin Familial Amyloid Polyneuropathy: Impact of Tafamidis
    Suhr O.B.
    Conceição I.M.
    Karayal O.N.
    Mandel F.S.
    Huertas P.E.
    Ericzon B.-G.
    Neurology and Therapy, 2014, 3 (2) : 101 - 112
  • [44] Diagnosis of sporadic transthyretin Val30Met familial amyloid polyneuropathy: a practical analysis
    Koike, Haruki
    Hashimoto, Rina
    Tomita, Minoru
    Kawagashira, Yuichi
    Iijima, Masahiro
    Tanaka, Fumiaki
    Sobue, Gen
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2011, 18 (02): : 53 - 62
  • [45] Recent advances in the treatment of familial amyloid polyneuropathy
    Adams, David
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2013, 6 (02) : 129 - 139
  • [46] Cardiac amyloid in patients with familial amyloid polyneuropathy consists of abundant wild-type transthyretin
    Yazaki, M
    Tokuda, T
    Nakamura, A
    Higashikata, T
    Koyama, J
    Higuchi, K
    Harihara, Y
    Baba, S
    Kametani, F
    Ikeda, S
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 274 (03) : 702 - 706
  • [47] FAMILIAL AMYLOID POLYNEUROPATHY RELATED TO TRANSTHYRETIN GLY42 IN A JAPANESE FAMILY
    UEMICHI, T
    UENO, S
    FUJIMURA, H
    UMEKAGE, T
    YORIFUJI, S
    MATSUZAWA, Y
    TARUI, S
    MUSCLE & NERVE, 1992, 15 (08) : 904 - 911
  • [48] Transthyretin familial amyloid polyneuropathy (TTR-FAP): Parameters for early diagnosis
    Escolano-Lozano, Fabiola
    Barreiros, Ana Paula
    Birklein, Frank
    Geber, Christian
    BRAIN AND BEHAVIOR, 2018, 8 (01):
  • [49] Early detection of nerve injury in transthyretin-related familial amyloid polyneuropathy
    Morrow, Jasper M.
    Reilly, Mary M.
    BRAIN, 2015, 138 : 507 - 509
  • [50] Long-term effects of tafamidis for the treatment of transthyretin familial amyloid polyneuropathy
    Teresa Coelho
    Luis F. Maia
    Ana Martins da Silva
    Márcia W. Cruz
    Violaine Planté-Bordeneuve
    Ole B. Suhr
    Isabel Conceiçao
    Hartmut H.-J. Schmidt
    Pedro Trigo
    Jeffery W. Kelly
    Richard Labaudinière
    Jason Chan
    Jeff Packman
    Donna R. Grogan
    Journal of Neurology, 2013, 260 : 2802 - 2814
12345